Condition
Hypopnea Syndrome
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results50% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Completed1
Recruiting1
Terminated1
Unknown1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04606693Not ApplicableRecruiting
Value of Screening and Treatment of SAHS in the Management of AF Ablation Candidates
NCT04577937Not ApplicableUnknown
Sleep Patterns in Patients Affected by Lymphangioleiomiomatosis
NCT00620659Phase 2Terminated
Treatment of Refractory Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnea/Hypopnea Syndrome (OSA/HS) Using Nasal Continuous Positive Airway Pressure (nCPAP) Therapy (0249-015)
NCT01188291Completed
Retinal Nerve Fiber Layer Thickness Measurements in Patients With Sleep Apnea Syndrome
Showing all 4 trials